간세포암종 환자에서 간동맥화학색전술 후 급성 신부전의 빈도 및 위험인자
Incidence and risk factors of acute renal failure after transcatheter arterialchemoembolization for hepatocellular carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims: Transcatheter arterial chemoembolization (TACE) is a major modality in the treatment of unresectable hepatocellular carcinoma. Acute renal failure (ARF) may occur after TACE because of underlying liver cirrhosis and the presence of radiocontrast agent. However, the data available regarding this complication are variable and limited. The aim of this study was to determine the incidence and associated risk factors of ARF after TACE. Methods: From January 2001 to December 2004, a total of 632 procedures were performed in 377 patients. Of these, the cases with high creatinine levels (≥ 2 mg/dL) before TACE and with incomplete medical records were excluded, which resulted in 463 procedures in 319 patients (256 males and 63 females; age 58.7±9.9 years, mean±SD) being examined for this study. Various clinical and radiological data before and after the procedure were reviewed retrospectively. Results: ARF occurred following 15 (3.2%) of the 463 procedures within 7 days of TACE. Univariate analysis revealed that serum albumin levels (P=0.025), Model for End-Stage Liver Disease score (P=0.001), the distribution of Child-Pugh class (P=0.027), and the proportions of patients with ascites (P<0.001), using diuretics (P=0.010), and with a serum creatinine level ≥ 1.5 mg/dL (P=0.023) differed significantly between patients with or without ARF after TACE. In multivariate analysis, the presence of ascites (P=0.005; odds ratio, 5.297) and serum creatinine level ≥ 1.5 mg/dL (P=0.007; odds ratio, 7.358) were independently associated with the development of ARF. Conclusions: The incidence of ARF after TACE was 3.2%, and the presence of ascites and an abnormal baseline serum creatinine level were the risk factors for ARF.
Abstract
Background/Aims: Transcatheter arterial chemoembolization (TACE) is a major modality in the treatment of unresectable hepatocellular carcinoma. Acute renal failure (ARF) may occur after TACE because of underlying liver cirrhosis and the presence of radiocontrast agent. However, the data available regarding this complication are variable and limited. The aim of this study was to determine the incidence and associated risk factors of ARF after TACE. Methods: From January 2001 to December 2004, a total of 632 procedures were performed in 377 patients. Of these, the cases with high creatinine levels (≥ 2 mg/dL) before TACE and with incomplete medical records were excluded, which resulted in 463 procedures in 319 patients (256 males and 63 females; age 58.7±9.9 years, mean±SD) being examined for this study. Various clinical and radiological data before and after the procedure were reviewed retrospectively. Results: ARF occurred following 15 (3.2%) of the 463 procedures within 7 days of TACE. Univariate analysis revealed that serum albumin levels (P=0.025), Model for End-Stage Liver Disease score (P=0.001), the distribution of Child-Pugh class (P=0.027), and the proportions of patients with ascites (P<0.001), using diuretics (P=0.010), and with a serum creatinine level ≥ 1.5 mg/dL (P=0.023) differed significantly between patients with or without ARF after TACE. In multivariate analysis, the presence of ascites (P=0.005; odds ratio, 5.297) and serum creatinine level ≥ 1.5 mg/dL (P=0.007; odds ratio, 7.358) were independently associated with the development of ARF. Conclusions: The incidence of ARF after TACE was 3.2%, and the presence of ascites and an abnormal baseline serum creatinine level were the risk factors for ARF.
참고문헌 (19)
- The Korean Liver Cancer Study Group, "The general rules for the study of primary liver cancer. 2nd ed" (2004), The Korean Liver Cancer Study Group
- Cheon JH, "The clinical report of 1,078 cases of hepatocelluar carcinomas: National Cancer Center experience", Korean J Hepatol, 10, pp.288~297 (2004)
- Kuroda C, "Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study", Radiology, 149, pp.85~89 (1983)
- Katsushima S, "Hepatic neoplasms: effects of transcatheter arterial embolization on coagulation and fibrinolysis", Radiology, 174, pp.747~750 (1990)
- Katsushima S, "Acute hepatic failure following transcatheter arterial embolization for the treatment of hepatocellular carcinoma", Digestion, 58, pp.189~195 (1997)
- Huo TI, "Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome", Aliment Pharmacol Ther, 19, pp.999~1007 (2004)
- Huo TI, "Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study", Liver Int, 24, pp.210~215 (2004)
- Moreau R, "Acute renal failure in patients with cirrhosis: perspectives in the age of MELD", Hepatology, 37, pp.233~243 (2003)
- Follo A, "Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis", Hepatology, 20, pp.1495~1501 (1994)
- Cardenas A, "Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis", Hepatology, 34, pp.671~676 (2001)
- Gines P, "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis", Gastroenterology, 94, pp.1493~1502 (1988)
- Sort P, "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis", N Engl J Med, 341, pp.403~409 (1999)
- Schrader R, "Contrast material-induced renal failure: an overview", J Interv Cardiol, 18, pp.417~423 (2005)
- Aspelin P, "Nephrotoxic effects in high-risk patients undergoing angiography", N Engl J Med, 348, pp.491~499 (2003)
- Kim YS, "Clinical characteristics and risk factors of contrast dye nephrotoxicity in patients performing arteriography", Korean J Nephrol, 23, pp.248~255 (2004)
- Cavaliere G, "Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency", Nephron, 46, pp.128~133 (1987)
- Moreau R, "Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure", Nephron, 65, pp.359~363 (1993)
- Arroyo V, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23, pp.164~176 (1996)
- Guevara M, "Effects of contrast media on renal function in patients with cirrhosis: a prospective study", Hepatology, 40, pp.646~651 (2004)